Hysteresis-based supervisory control with application to non-pharmaceutical containment of COVID-19.
COVID-19
Hysteresis control
Supervisory control
Journal
Annual reviews in control
ISSN: 1367-5788
Titre abrégé: Annu Rev Control
Pays: England
ID NLM: 9891910
Informations de publication
Date de publication:
2021
2021
Historique:
received:
06
05
2021
revised:
07
07
2021
accepted:
20
07
2021
pubmed:
19
8
2021
medline:
19
8
2021
entrez:
18
8
2021
Statut:
ppublish
Résumé
The recent COVID-19 outbreak has motivated an extensive development of non-pharmaceutical intervention policies for epidemics containment. While a total lockdown is a viable solution, interesting policies are those allowing some degree of normal functioning of the society, as this allows a continued, albeit reduced, economic activity and lessens the many societal problems associated with a prolonged lockdown. Recent studies have provided evidence that fast periodic alternation of lockdown and normal-functioning days may effectively lead to a good trade-off between outbreak abatement and economic activity. Nevertheless, the correct number of normal days to allocate within each period in such a way to guarantee the desired trade-off is a highly uncertain quantity that cannot be fixed a priori and that must rather be adapted online from measured data. This adaptation task, in turn, is still a largely open problem, and it is the subject of this work. In particular, we study a class of solutions based on hysteresis logic. First, in a rather general setting, we provide general convergence and performance guarantees on the evolution of the decision variable. Then, in a more specific context relevant for epidemic control, we derive a set of results characterizing robustness with respect to uncertainty and giving insight about how a priori knowledge about the controlled process may be used for fine-tuning the control parameters. Finally, we validate the results through numerical simulations tailored on the COVID-19 outbreak.
Identifiants
pubmed: 34404974
doi: 10.1016/j.arcontrol.2021.07.001
pii: S1367-5788(21)00068-7
pmc: PMC8361045
doi:
Types de publication
Journal Article
Langues
eng
Pagination
508-522Informations de copyright
© 2021 The Author(s).
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Nat Commun. 2020 Oct 9;11(1):5106
pubmed: 33037190
Nat Med. 2020 Jun;26(6):855-860
pubmed: 32322102
Nat Med. 2021 Jun;27(6):993-998
pubmed: 33864052
Annu Rev Control. 2021;51:426-440
pubmed: 33935582
J Clin Virol. 2020 Jul;128:104440
pubmed: 32425658
PLoS Comput Biol. 2021 Jan 21;17(1):e1008604
pubmed: 33476332
Nature. 2020 Aug;584(7820):257-261
pubmed: 32512579
Annu Rev Control. 2020;50:417-431
pubmed: 32837241